Next Article in Journal / Special Issue
Dietary Supplements on Controlling Multiple Sclerosis Symptoms and Relapses: Current Clinical Evidence and Future Perspectives
Previous Article in Journal
Cervical Cancer Prevention in Racially Disparate Rural Populations
Previous Article in Special Issue
Investigation of Anthocyanins Stability from Pomegranate Juice (Punica Granatum L. Cv Ermioni) under a Simulated Digestion Process
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences

by
Melina Konstantinidi
and
Antonios E. Koutelidakis
*
Department of Food Science and Nutrition, University of the Aegean, Myrina, 81400 Lemnos, Greece
*
Author to whom correspondence should be addressed.
Medicines 2019, 6(3), 94; https://doi.org/10.3390/medicines6030094
Submission received: 6 August 2019 / Revised: 2 September 2019 / Accepted: 2 September 2019 / Published: 9 September 2019

Abstract

:
Background: Weight management and obesity prevention is a basic aim of health organizations in order to decrease the prevalence of various metabolic disorders. The aim of the present review article was the evaluation of the possible role of functional foods and their bioactive compounds as alternative way to promote weight management and prevent obesity and its metabolic consequences. Methods: Approximately 100 articles were selected from Scopus, PubMed, Google Scholar, and Science Direct, by using relative key words, and based mainly on recent animal, clinical or epidemiological studies. Results: The literature review highlighted the possible effect of specific functional foods such as coffee, green tea, berries, nuts, olive oil, pomegranate, avocado, and ginger. Specific bioactive compounds of those foods—such as caffeine, catechins, gallic acid, anthocyanins, ascorbic acid, polyphenols, oleuropein, capsaicin, and quercetin—may contribute to weight management, obesity prevention, and obesity’s metabolic consequences. The possible mechanisms include effect on satiety, lipid absorption, fatty acids beta oxidation, stimulation of thermogenesis, etc. Conclusions: Functional foods, as part of a balanced diet, could be useful in the direction of weight management and decrease of obesity’s’ metabolic consequences. However, the scientific evidence is unclear and in most cases controversial and more clinical and epidemiological studies are needed in order to further investigate the mechanisms of their possible effect.

1. Introduction

Obesity defined by the World Health Organization (WHO) as a condition characterized by inordinate accumulation of body fat and as a public health problem that lead to serious social, physical, and psychological problems. The body mass index (BMI) of 30 kg/m2 is the cut-off point for obesity, which have associated with increased risk for chronic diseases, morbidity, and mortality [1]. According to European studies, a growing health problem includes child obesity, especially in countries around the Mediterranean Sea that have shown very high rates of overweight and obesity. Surveys in Greece have noted that child obesity levels are the highest in Europe [2]. Although food portion control is very important issue for weight management, the exhortation of people to eat less of all foods may not lead to desirably results, given the fact that the high-energy-dense foods disproportionately increase energy intake in comparison with those with lower content in energy density. A more adequate strategy might be the encouragement of people increasing the consumption of low-energy-dense foods and limiting the consumption of high-energy-dense foods, in parallel with following a balanced diet, such as the Mediterranean diet, in combination with increase of physical activity [3].
Functional foods (FFs) were first defined in the 1980s, when the Ministry of Health and Welfare of Japan established a regulatory system for foods that possess possible health benefits. A food can be considered as ‘functional’ if it possesses constructive effects on target functions into the human organism, beyond nutritional effects, with aim of health promotion and wellbeing and/or the reduction of chronic diseases. Functional foods are attaining eminence globally and are part of the daily diet of consumers. By 2020, functional foods’ and beverages’ global market has been predicted to be worth $192 billion [4]. Functional foods are often indicated as ‘natural health products’ or ‘healthy foods’. Although there is not a unique definition worldwide, foods can only be considered functional if, along with basic nutritional impact, they exhibit possible beneficial effects on specific functions in the human organism with the result of improving the physical condition and/or decreasing the risk of chronic disease appearance [5,6]. However, nutritional and health claims about the possible effect of functional foods on disease prevention has been established only in specific situations, when sufficient scientific data ensure their properties. Furthermore, the scientific research concludes that functional foods may have beneficial effects in human health only if they are part of a balanced diet, such as the Mediterranean diet [7,8,9].
Bioactive compounds are present in small amounts into the food items and their effect on human health is being continuously investigated. Epidemiological data support that high intake of natural functional foods, such as specific fruits and vegetable, which are rich in bioactive compounds, is associated with decreased risk of chronic diseases, such as cardiovascular diseases, cancer, metabolic syndrome, diabetes type II, and obesity [10]. Natural bioactive compounds—such as resveratrol, epigallocatechin, curcumin, oleuropein, sulforaphane, quercetin, ellagic acid, anthocyanins, b-glucans, and other biomolecules—have been studied as factors with possible direct or indirect effect on specific molecular pathways, associated with the pathophysiology of cardiovascular diseases, diabetes, metabolic syndrome, and cancer. However, more clinical and epidemiological studies are essential in order to ensure their possible effect [7,8,9], given the fact that the conducted studies have different experimental designs and their result are, in many cases, controversial. Resveratrol (3,5,4-trihydroxystilbene) (RSV) has been detected mainly in grapes, red wine, and pomegranates and it is the main stilbene present in human diet. Epigallocatechin-3-gallate (EGCG) is the major polyphenol from green tea with high antioxidant and scavenging properties. It is the ester of gallic acid with epigallocatechin and characterized by two triphenolic groups. Curcumin (CUR) exhibit possible anti-inflammatory, antioxidant and chemo-preventive actions and it is a polyphenol from Curcuma longa Linnaeus (Zingiberaceae). Quercetin (QR) is a flavonol found in various foods, such as berries and tea; its antioxidant activity is the result of three important groups: the 4-oxo group in combination with the 2,3-alkene, 3- and 5-hydroxyl groups, and the hydroxyl groups of B ring. Ellagic acid (EA) applies high antioxidant and radical scavenging activity and it is a polyphenol derived from ellagitannins mostly found in nuts and berries. Anthocyanins (ACs) are water-soluble pigments with purple, red, and blue colors and present in fruits, especially in pomegranate, berries, and red grapes. Anthocyanins have studied as bio-functional molecules with possible high anti-inflammatory, antioxidant, and chemoprotective effects [11].
Obesity is a metabolic disease, which has become a problem of epidemic spread at European and global level and is related with other chronic degenerative or inflammatory diseases and metabolic consequences [7]. Increased food consumption, decreased physical activity, positive energy balance, and food addiction are parameters that may lead to increased obesity levels globally. The often consumption of foods that are of high content in sugar and fat, in combination with strong cravings or compulsions, is characterized as food addiction [12,13]. The strategies for weight control management and obesity prevention or treatment include increase of energy expenditure and following of a balanced diet in order to achieve negative energy balance. In recent years, it has been observed that an increase in efforts has been made for finding and applying alternative ways to prevent obesity, in order to decrease the impact and the cost of its metabolic consequences. The scientific community, based mainly on clinical and epidemiological studies, highlights the importance and the possible health effects of certain foods, so-called functional foods. The incorporation into a diet of several natural or processed foods with possible health effects, such as functional foods, may contribute to the weight management, if they are combined with the following of a balanced diet [7,8]. In recent study, with 300 healthy volunteers, the authors noticed a decreased BMI in those who often consumed gojiberry, cranberry, and pomegranate in contrast to those who had never consumed these functional foods [7]. In addition, scientific data support that the consumption of specific functional foods and bioactive compounds, such as b-glucane, glucomanane, foods with reduced fat and sugar content, etc., may contribute to weight management and metabolic consequences in obese people and could be part of a balanced diet for obesity management or treatment. However, the scientific data underline that these specific functional foods and bioactive compounds cannot contribute to weight control if consumed unilaterally and in large quantities.
The aim of the present review article was to conduct a critical literature survey in order to present, highlight, and discuss recent studies about the possible role and effect of specific bioactive compounds and functional foods on weight management, and obesity’s metabolic consequences, including cardiovascular diseases, hypertension, metabolic syndrome, and diabetes mellitus. For that scope, approximately 100 articles were selected from Scopus, PubMed, Google Scholar, and Science Direct, by using relative key words, and based mainly on recent animal, clinical, or epidemiological studies. The 100 articles selected from a larger number of articles, with the use of combinations of specific key words—such as ‘obesity’, ‘metabolic disorders’, and ‘functional foods’—and the names of bioactive compounds and functional foods that their role on weight control have studied the last years. The selection performed by specific criteria and specifically: a) recent articles published mainly the last decade; b) articles which present animal experiments, human clinical trials, and epidemiological studies; c) selection of functional foods that are studied as possible factors for weight management in an important number of recent studies.

2. Recent Data about The Possible Effect of Specific Functional Foods and Their Bioactive Compounds on Weight Control and Obesity’s Metabolic Consequences

Animal experiments as well as clinical studies have been performed in order to investigate the possible effect of functional foods and bioactive compounds on weight control and the metabolic consequences of obesity. The studies present different conclusions due to different experimental designs and target groups and the results, in some cases, are unclear and controversial. Most studies present some indications, but no clear evidence. The results from animal studies lead to different and no clear results. In a recent study, the consumption of 68.3 mg/kg decaffeinated green coffee beans from 40 male rats for 11 weeks resulted in body weight gain and increased cardiovascular diseases [14]. However, in another study the consumption of 100 mg capsules or powder of green tea from 10 male rats for 30 days led to reduced body weight gain [15]. In a recent study has been observed that the consumption of 20–60 mg/day oleuropein powder from 8 male rats for 4 weeks led to increased blood pressure and glucose [16]. Other study concluded that the consumption of 2 g avocado from 35 male rats for 7 weeks led to increased cholesterol but reduced body weight, blood glucose, BMI, and serum lipids [17]. Finally, the consumption of 500 mg/kg ginger from rats for 30 days led to increased liver weight but decreased plasma glucose levels [18].
Table 1 present selected animal studies about the possible effect of functional foods in weight control, obesity, and its metabolic consequences (glucose and lipids levels). The animal studies could present a first indication about the possible role of some functional foods on weight control; however, human studies are essential for safer investigation. The animal experiments in obesity models were performed with various experimental designs, doses of bioactive compounds, and metabolic diseases; so the results could not be reliable for general conclusions.

2.1. Coffee and Green Coffee

Coffee is one of the major non-alcoholic beverages and most widely consumed pharmacologically active beverages worldwide. Green beans of coffee are essentially non-roasted coffee beans and green coffee grounds can be viewed as one of the most important types of grain traded worldwide [23,24]. Coffee cultivation began in Arabic from Ethiopia centuries ago; it continued to flourish in countries such as Africa, Latin America, and Asia. Coffee is often composed by a variety of crops of roasted beans and consists of two species, Coffea canephora and Coffea Arabica, which can be found in organic and conventional types [25]. Nowadays, coffee is the second most traded commodity worldwide and has emerged as a cultural phenomenon with the consumption of hundreds of billions of cups every year [26].
According to the Dietary Guidelines Advisory 2015 it is noted that people should consume up to about 400 mg dose of coffee in either capsule or powdered form—i.e., about 2–3 coffee cups per day. In a recent study the authors observed in healthy adults that moderate coffee consumption (3–5 cups/day or up to 400 mg/day caffeine) was not associated with increased risk of major chronic diseases prevalence, such as cardiovascular disease, premature death and cancer [27]. However, the scientific data support that, above this level, consumption exhibits negative consequences.

2.1.1. Bioactive Compounds of Coffee and Green Coffee

One of the most important bioactive components of coffee is the methyl-xanthine alkaloid caffeine, which consist the 1.2–2.2% of coffee. Caffeine is a dietary compound which appears stimulant action, is not a nutrient and occurs in plants like coffee beans. Chlorogenic acids are other important bioactive compounds, found especially in green coffee, in Coffea arabica and Coffea canephora seeds and include caffeoylquinic acid, dicaffeoylquinic acid, feruloylquinic acid, p-coumaroylquinic acid, and caffeolyl-feruloylquinic acid. During the roasting process, roast coffee is rich in a variety of compounds which provide aroma, flavor, and color due to the chemical reactions [15,27]. Roasting coffee contains plethora of bioactive compounds and its chemical composition is the following: 2.7–3.1% chlorogenic acid, 1.2–2.4% caffeine, 23% melanoidins, 11–17% lipids, 38–42% carbohydrates, 10% proteins, and 2.4–2.5% aliphatic acids. The roasting process increases the soluble dietary fiber from 39.4 mg per 100 g in green beans to 64.9 mg per 100 g in roasted beans. The chemical composition of green coffee beans before roasting process is the following: 6.5–10% chlorogenic acid, 1.2–2.2% caffeine, 10–16% lipids (mainly the diterpenes cafestol and Kahweol), 0.7–1.0% trigonelline, 45–52% carbohydrates, 11% proteins, and 4.2–4.4% minerals [15].

2.1.2. Possible Effect of Coffee and Green Coffee on Human Health

Scientific data conclude that moderate coffee consumption is associated with decreased risk of diabetes mellitus type II and cardiovascular disease in adults. Moreover, some evidence indicates possible association between caffeine intake and reduced risk of Parkinson’s disease [27]. The frequent consumption of a green or roasted coffee may be beneficial to healthy and hypercholesterolemic subjects in order to avoid metabolic syndrome (MetS), as it may exhibit positive effects on blood pressure, serum glucose and triglyceride levels, being especially interesting for subjects with hypercholesterolemia, as coffee improved the lipid profile [28]. In another study 68.3 mg/kg dose of coffee was administrated to 40 male rats with metabolic syndrome, cardiovascular and hepatic structure for 8–9 weeks and concluded increased cardiovascular diseases [14]. In a randomized control blinded trial, the consumption of 500 mg dose of caffeine in capsules or powder form to 137 patients with arrhythmic episodes for 2 months and resulted no arrhythmic episodes [29]. However, other studies have recently underlined the possible negative effects of the increased consumption, such as cardiac arrhythmia, etc.

2.1.3. Possible Effect of Coffee and Green Coffee on Weight Control

In Table 2 recent human interventional clinical studies about the possible effect of coffee on body weight control and diseases prevention are summarized. Although, several scientific studies support that green coffee consumption may contribute to weight management the scientific data remain unclear. In a recent study green coffee bean extract significantly decreased body weight and fat mass. The authors concluded that in addition to the antioxidant activity of coffee, coffee consumption may possible lead to significantly declined body weight and body fat [26]. In a randomized controlled trial the consumption of 3–5 cups/day of coffee for 3 weeks in 25 males and 95 females with obesity led to contribution to the weight control and increased number of Bifidobacterium spp [15,27]. In onother study the authors used coffee silverskin from Arabic and Robusta varieties (Coffea Arabica and Coffea canephora, respectively) as raw materials. The main bioactive component that used for comparative analysis was tablets of decaffeinated green coffee extract and CGA (5-caffeoyl quinic acid). About beverages, there were bags containing samples and were prepared using 10–20 μm filter papers and infused in boiling water for different time points. Brewing conditions were optimized by studying influence of: (a) raw material; (b) extraction time, 5 and 10 min; (c) concentration of raw material (2.5, 5, and 10 mg/mL); and (d) coffee variety. They observed in humans that coffee consumption prevented fat accumulation and excess weight [30]. In several studies, the green coffee bean extract showed stronger effect on body weight reduction and on decrease of epididymal and perirenal fat weight than roasted coffee and caffeine, possibly due to its high content on chlorogenic acids. Coffee may also influence gut microbiota in animals and humans with obesity. Although the possible anti-obesity mechanism of coffee still needs further investigation, it might have prospective as a new strategy for weight management [15]. We can summarize that coffee is one of the beverages that some indications exist about its role on weight management. Although consumption of coffee and green coffee led to weight control in several studies, especially by reduction in BMI, further studies are needed in order to fully investigate the possible effects on weight management and human health.

2.2. Tea and Green Tea

Many studies support that polyphenols in tea may contribute to reducing cardiovascular disease and type II diabetes mellitus, lowering risk of obesity, lowering cholesterol, and low-density lipoprotein (LDL), as well as having anti-atherosclerotic properties and it may reduce various forms of cancer. Laboratory and animal studies showed that green tea, and in particular EGCG, seems to help control weight by reduction of adipocyte proliferation, impeding the absorption of fat and reduction of blood triglycerides, cholesterol, glucose, and insulin [36,37,38,39,40]. According to the literature review, green tea is the functional beverage with the most studies conducted and with some clear evidence about its possible effect on weight control; however, more studies are needed for safer results.

2.2.1. Bioactive Compounds of Green Tea

Green tea constitutes a beverage rich in polyphenolic compounds, especially epigallocatechin gallate (EGCG), catechin (C), galactatechin (GC), epigallocatechin (EGC), epicatechin (EC), and galactoatechin gallate (GCG). Tea bioactivity is based mainly on the antioxidant activity of tea polyphenols and is affected from various nutritional and physiological parameters [41]. Although the majority of clinical studies are not designed for safety evaluation of dietary bioactive compounds, safety results of great value are reported in clinical efficacy studies and are used to establish the efficacy levels of bioactive compounds on target populations [36]. The antioxidant mechanism of tea polyphenols has been determined by in vitro and in vivo analyses. The fermentation process affects tea bioacative components and thus changes its antioxidant activity. In a recent study the authors used Taiwanese tea and especially four types—which include green (non-fermented), oolong (semi-fermented), black (fully fermented), and Pu-erh (post-fermented) tea—at different degrees of fermentation and determined the polyphenol levels by high performance liquid chromatography (HPLC). The study observed a clear correlation between gallic acid content and the degree of fermentation; the lowest gallic acid concentration was 1.67mg/g in Pu-erh tea, while the highest was 21.98 in green tea [38].

2.2.2. Possible Effects of Tea on Weight Control: Possible Mechanisms

Animal and human studies have shown that tea catechins may help on weight control but the results are controversial. Treatment of rats with EGCG indicated reduction on food intake, while EGCG has proposed as a factor with possible contribution on weight loss. Green tea catechins (GTC) attenuated the increase on body and liver weights and improved serum and liver triglyceride levels. Rats fed a chow diet had more weight reduction than rats fed a high fat diet, while GTC supplementation significantly decreased body weight [37]. Although some animal studies showed possible effect on weight control and especially led to reduce weight control, human studies have not fully ensured these results. More epidemiological studies with large sample may supplement the existing indications about the role of green tea on weight management. However, the scientific data about the effect of tea on metabolic biomarkers, such as cardiovascular and diabetic indexes are clearer and show possible positive effects.
Two possible mechanisms of green tea polyphenols effect on weight management are: (i) tea components may decrease lipids’ and proteins’ absorption into the intestine, consistently reducing calorie intake; and (ii) tea polyphenols activate AMP-activated protein kinase which is bioavailable in liver, skeletal muscle, and adipose tissue. The importance of these two mechanisms is depended on the tea type and the consumed diet by individuals [42]. Possible beneficial effects on body-weight management have been observed from mixing green tea catechins with caffeine; studies showed maintenance or reduction of body weight, which possibly caused by increase on energy expenditure, thermogenesis and fat-oxidation [43,44,45,46]. In other studies the consumption of 100 mg tea catechins in capsules or powder from 10 male rats with obesity for 30 days led to the reduction of body weight gain [14,37]. In a randomized control blinded trial, was observed that the consumption of 704 mg tea catechins per day from 40 males and 37 females with liver problem for 14 days did not have an adverse effect on liver [47]. A randomized controlled, blinded trial concluded that the consumption of 491 mg tea catechins per day in capsule form by 115 obese women for 12 weeks led to significant weight reduction [48]. In another study the authors administrated 90 mg epigallocachin-3 gallate in capsules form to 8 young men with thermogenesis and concluded that tea catechins stimulated thermogenesis [43].
Table 3 presents several human intervention clinical studies about the possible effects of green tea on weight management and disease prevention. Most of the studies used randomized and controlled design with consumption of about 3–5 cups tea per day for several weeks and showed a small reduction on weight or BMI and improvements on metabolic biomarkers.

2.3. Berries

2.3.1. Bioactive Compounds of Berries

Berries are rich in phenolic compounds, such as anthocyanins, flavonols, flavanols, proanthocyanidins, ellagitannins, and phenolic acids, with anthocyanins being the stronger pigments, responsible for the red, blue, or purple color in berries, which act as powerful antioxidants. One kind of berries, aronia, contains polyphenols with anti-inflammatory activities. Scientific evidence support that aronia berry consumption may modulates intestinal immune function and T-cells [20,55].
Berries—such as blackberry, blueberry, strawberry, etc.—are one of the best dietary sources of bioactive components, which may exhibit a synergistic and cumulative effect on human health promotion and possible prevention of chronic diseases such as obesity, hypertension, type II diabetes mellitus, dyslipidemia, and nonalcoholic fatty liver disease. Berry consumption can be considered as an effective alternative way of dietary pattern modifications focused on decreasing the development of metabolic syndrome. Clinical studies have shown that the long-term consumption of berries in patients with metabolic syndrome may provide beneficial results to their health. Moreover, berry consumption may protect from cardiovascular metabolic consequences [56,57].

2.3.2. Possible Effects of Berries on Weight Management and Obesity’s Metabolic Consequences

It has been observed that the administration of aronia berry in mice raised the colonic IL-10 secretion, while 4.5% of aronia berry did not constrain ex vivo stimulated cytokine production by colon and spleen tissue. Unstimulated colon tissue ex vivo excretion of IL-10 was raised by 100% in the aronia fed mice, in comparison to the control group (p = 0.0348). IL-17 and IL-6 were not importantly different in the aronia-fed mice (p = 0.0535 and p = 0.0850, respectively) [36]. According to animal studies and controlled clinical trials, a possible anti-obesity effect of berries was observed via a decrease in body fat and waist circumference. In several studies, berries suppressed increased liver and epididymal fat weight, fasting blood glucose, triglycerides, and LDL-C levels [56,57]. The administration of 500 mg dose of berries’ anthocyanins in powder form from 80 rats with chronic diseases for 7 weeks led to the reduction of metabolic chronic diseases [19]. In a randomized controlled blinded trialthe consumption of 100–140 mg/day of berries in capsules form from 63 participants with diabetes mellitus for 12 weeks increased the glycemic control [58]. In a randomized controlled trial the consumption of 163 g berries per day from 61 women for 20 weeks, increased fasting plasma HDL, and decreased systolic and diastolic blood pressure [59]. The consumption for 5 weeks of 414.2 mg/day berries’ anthocyanins from 40 healthy older adults with type II diabetes mellitus, improved type II diabetes consequences, and cardiovascular diseases’ biomarkers [57]. In another study, the complementation of a high-fat diet with berries prevented weight gain and declined insulin resistance [60]. The consumption of black berries (BB) led to reduced average 24 h respiratory quotient (RQ) (0.810 vs. 0.817, BB vs. gelatin, GEL, p = 0.040), increased fat oxidation and improved insulin resistance in overweight or obese males fed a high fat diet. RQ reduction correlated with 7% raise in fat oxidation (141 g/day for BB vs. 132 g/day for GEL, p = 0.0420); in the evening the fat oxidation increased to 14% (28 g for BB vs. 25 g for GEL, p = 0.0069), during the morning increased to 11% (21 vs. 19 g, BB vs. GEL, p = 0.0129), while during exercise raised to 12% (9 vs. 8 g, BB vs. GEL, p = 0.0044). A randomized crossover study with consumption of 600 g blackberries daily for one week, concluded that blackberry consumption significantly increased fat oxidation and decreased insulin resistance in overweight or obese men followed a high-fat diet in comparison with an energy matched control diet [61].
As a conclusion, we can underline that although many studies have shown the possible effect of berries on metabolic biomarkers, the studies about their effect on weight management are limited; more clinical and epidemiological studies are needed in a large number of individuals for a long time so as to draw more clear conclusions about the effect of berries on weight control.

2.4. Pomegranate

Pomegranate (Punica granatum L.) is rich in tannins, especially ellagitannins, as well as flavonoids such as catechins, epicatechin, quercetin, anthocyanins, and procyanidins, all bioactive compounds that may contribute to possible health benefits [62,63]. Pomegranate belongs to Punicaceae family and is a fruit with strong antioxidant activity, involving bioactive phenolic components with possible health benefits. Pomegranate peel accounts for 30–40% of the fruit and constitutes a juice byproduct, which is considered an unused material [64]. Pomegranate decreases fasting serum glucose levels as it contains anthocyanins and tannins such as punicalagin, ellagic, and gallic acids that might possess anti-diabetic actions. Pomegranate may affect type II diabetic pathophysiology by reduction of oxidative stress and lipid peroxidation [65]. Both pomegranate seeds and juice may contribute to the prevention of the most important chronic diseases, including cancer, cardiovascular disease, diabetes mellitus, and obesity [66].
Anthocyanins are considered of high importance among pomegranates’ bioactive phenolic compounds. Hydrolysable tannins, especially ellagitannins and gallotannins, form the most prevalent compounds in pomegranates, so they are present in all the parts of the plant. Pomegranates’ bioactivity is possibly the result of these compounds; the main pomegranate ellagitannins are punicalagins and granatins [63,64]. Moreover, pomegranates’ peels are used in fruit processing industry as new sources of bioactive compounds with possible utilize in food industry for novel functional foods production [64]. The consumption of 50 mg of powder pomegranate from 6 dogs led to positive impact on gut health [22]. The consumption of pomegranate leaf extract and 10–20 mg of ascorbic acid from pomegranate in capsules or powder form from a large sample led to the treatment of obesity and type II diabetes and decreased body weight [67]. The literature review showed that the studies about the possible role of pomegranate on weight loss are limited, while several studies have been performed about its role on obesity’s metabolic consequences.
Table 4 presents several human intervention studies about the possible effects of berries and pomegranate on body weight control, obesity, and its metabolic consequences.

2.5. Nuts and Seeds

2.5.1. Bioactive Compounds of Nuts

Nuts and seeds are considered basic components of a healthy diet, such as the Mediterranean diet. According to some epidemiologic studies, adding nuts to a diet does not cause weight gain. Also, nuts intake reduced the risk of cardiovascular disease (CHD), reduced type II diabetes mellitus, and influenced risk of hypertension and risk of heart failure. With the exception of chestnuts, lipids are the main ingredients in nuts and seeds, followed by protein and carbohydrates; thus, nuts and seeds appear a high energy content [69,70]. Nuts contain increased amounts of nutrients including fiber, monounsaturated fatty acids (MUFA), polyunsaturated fatty acids (PUFA), vitamin E, folate, magnesium, potassium, and calcium and in parallel have decreased levels of saturated fatty acids (SFA). Walnuts, particularly, are an excellent source of a-linolenic acid, which is an important omega-3 fatty acid that decreases cardiovascular disease incidence and possibly the risk of cancer [71]. The main polyphenol in walnuts is pedunculagin, an ellagitannin, which is hydrolyzed after consumption, in order to release ellagic acid, which is converted by gut microflora to urolithin A and other substances, as urolithins B, C, and D. Ellagitannins (ETs) retain antioxidant and anti-inflammatory bioactivity and may contribute to the attenuation of the onset and progression of cancer, cardiovascular, and neurodegenerative diseases [72].
Nuts are made up of 50–75% fat, yielding an average of 5–7 kcal/g, of which the least is saturated, while most are monounsaturated and polyunsaturated, which places among high-nutrition foods. For instance, peanuts are rich in monounsaturated fat, with more than 80% oleic acid, while nuts are characterized by their high content of α-linolenic acid, a short chain omega-3 polyunsaturated acid. Nuts are also a rich source of protein (about 25% of their total energy), and for the peanuts there is an extremely high L-arginine content. Only 15% of their total energy comes from carbohydrates, while they are a rich source of fiber, ranging from 4 to 11% of total weight [73]. Therefore, nuts are foods with high energy content.

2.5.2. Possible Effects of Nuts on Weight Control: Possible Mechanisms

In developed countries, there is an increase in overweight and obese people, especially adults, due to the increased energy consumption and unbalanced nutrition. In a recent studythe participants maintained levels of physical activity to ensure the stability of the weight. Also, the participants had the intention of replacing the fat or protein foods in their diet and consuming walnuts during the day as a snack. The study resulted reduction in systolic blood pressure, while no change on baseline anthropometric characteristics was observed [74]. In another study, a healthy diet containing one daily serving of nuts for 12 weeks had little effect on lipid profile of metabolic syndrome (MetS) patients but led to improvement on insulin sensitivity and a marginal anti-inflammatory effect, in combination with moderate weight loss. Therefore, regular nut consumption could help patients with MetS, although changes in cholesterol metabolism make them resistant to cholesterol lowering [75]
The consumption of 85.2 g of walnuts from 40 male rats with increased blood glucose level for 2 weeks reduced the blood glucose levels [21]. In a randomized control trial for 12 weeks the consumption of 30 g/day of cashew nuts from 300 adults with type II diabetes, increased HDL cholesterol, body weight, BMI, waist circumference, and decreased systolic blood pressure [76]. In other randomized control trial the consumption of 50 g of walnuts from 63 patients with prostate cancer or prostate hyperplasia improved prostate biomarkers [72]. The consumption of 30g of nuts from 50 patients with insulin resistance for 12 weeks led to decreased insulin resistance [75]. The consumption of 56 g of walnuts from 46 overweight, obese adults (28 women and 18 men) for 4 weeks concluded improvement of endothelial function in the overweight participants, but the body weight was unchanged [77]. In a randomized control study the consumption of 43 g of almonds from 137 participants with postprandial glycemia concluded that hunger suppressed [78]. All the above studies concluded that nuts consumption improved metabolic biomarkers and could be an ideal source of fat, by replacing saturated fatty acids.
Several studies support that because nuts are energy dense, they should be replaced from other foods into the diet in order to control calories and attenuate an excess energy intake and weight gain [74]. The high energy density of nuts may lead to the conclusion that their consumption promotes weight gain. However, the US Department of Agriculture’s Continuing Survey of Food Intakes concluded that BMI from 12,000 participants was lower among nuts consumers (23.8 ± 0.1 kg/m2 ) in contrast to those who never ate nuts (25.0 ± 0.1 kg/m2), despite the higher energy intakes of nuts (2191 ± 20 kcal/day compared to 1997 ± 9 kcal/day, respectively). In comparison with the carbohydrate low calorie diet, the group with almond-low calorie diet appeared 62% more greater decrease in weight, 50% in waist circumference, and 56% in fat mass and showed greater improvements in glycemic control. After eating nuts, it seems that appetite suppression occurs which may be attributed their high energy content, proteins, and fiber, which can cause a feeling of satiety. Possible causes for weight control after nuts consumption are increased satiety, energy consumption, or energy malabsorption [73].
Table 5 presents several human intervention studies about the possible effects of nuts on body weight control, obesity, and its metabolic consequences. The studies that reviewed concluded, in the most of cases, that nuts are functional foods which do not lead to increase on body weight, although they contain high fat content; however, they may lead to decreasing rhythm of weight gain or to weight loss, while they contribute to important improvements on metabolic profile, serum lipids, and glycemic control.

2.6. Olive Oil

Olive oil is derived from the fruit of the olive tree (Olea europea) [17]. The bioactive compounds of olive oil—such as polyphenols, oleic acid, and tocopherols—have been studied as factors with possible contribution to the multifactorial metabolic and vascular protective effect afforded by Mediterranean diets. Oleuropein is the most important bioactive and phenolic compound of olive oil and its leaves [79]. The consumption of olive oil has been correlated with longevity and associated with reduction on risk of morbidity and mortality. In Mediterranean diet, olive oil has been associated with decreased risk of cardiovascular disease and cancer [80,81]. Olive oil constitutes a main source of fat, while the health benefits of olive oil consuming were attributed to the high content in oleic acid. Nowadays, it is well established that the beneficial effects of olive oil could be attributed to both oleic acid content and the phenolic fraction and has been associated with antioxidant, anti-atherosclerotic, anti-inflammatory, and anti-microbial activities [79,82].

Possible Effects of Olive Oil on Weight Control and Obesity’s Metabolic Consequences

The consumption of olive oil increased the body weight, as well as the waist circumference in several human studies, due its high fat content. However, the high consumption of olive oil was not correlated with higher weight gain and increased risk of overweight and obesity developing. The bioactive compounds of olive oil may contribute to a different way and rhythm of body weight gain, and olive oil consumption according the guidelines may contribute to weight management in obese patients. Several studies found that weight, waist circumference, and blood pressure decreased after olive oil consumption. Olive oil, in contrast to sunflower oil, led to decreased weight, waist circumference, blood pressure, and body fat percentages. Sunflower oil caused decline in skeletal muscle mass between the different groups. After the consumption of olive oil, the conservation of muscles and the promotion of fat tissue loss were valuable [16,83]. A randomized controlled trial observed that the consumption of 20–60 mg/day of oleuropein in powder form from 8 male rats with type II diabetes for 4 weeks led to increase in blood pressure and glucose [16]. Another randomized controlled and blinded trial concluded that the consumption of 70–398 mg of phenolics of olive oil from 20 patients with metabolic syndrome reduced cardiovascular diseases biomarkers [84]. In another randomized controlled and blinded trial the authorsobserved that the consumption of 30 mg/day polyphenols of olive oil from 24 young women with mild hypertension for 2 months decreased blood pressure [85]. Other studies showed that the consumption of 20 g/d olive oil from 93 male patients with insulin resistance led to the reduction of insulin resistance and of BMI [17,86].
A literature survey showed that although the results of the studies are contradictory, there is evidence which clearly supports the possible effect of olive oil consumption, according to dietary guidelines, on weight management, as an ideal alternative source of fat instead of saturated fats; almost all the studies show positive effect of olive oil on metabolic indices.

2.7. Avocado

Avocado (Persea Americana) is a fruit which belongs to the berry family, containing more than 400 varieties [17]. Avocado is a lipid-rich food, with provitamin A carotenoids which appeared the maximum absorption and the greater conversion to vitamin A, especially in populations with vitamin A deficiency [87]. Avocados are a bioavailable source of lutein [88] and are fruits with medium energy density, given the fact that about 80% of the avocados’ edible portion consists of water (72%) and dietary fiber (6.8%); avocado has been found to exhibit similar effects on weight management as low-fat fruits and vegetables [89]. Diets rich in avocado may improve lipoprotein profile with increase in high-density lipoprotein (HDL) and decrease in low-density lipoprotein (LDL) [88].

Possible Effects of Avocado on Weight Control and Health Promotion

Recent studies concluded that the consumption of 2 g of avocado pulp from 35 male rats with increased blood glucose and serum lipids for 7 weeks increased cholesterol but reduced body weight, blood glucose, BMI, and other serum lipids [17,90]. The consumption of 75 g dose or ~ ½ of a Hass avocado from 26 overweight and moderate obese adults with increased blood glucose and insulin, for 1 week at a lunch meal influenced satiety after ingestive, over subsequent periods of 3 and 5 hours. Satiety is one of the functions of the appetite system, which leads to development of completeness after a meal and decrease in hunger and restriction of further eating in the postprandial period. Specifically, a lunch meal rich in avocado led to a 23% increase in satisfaction and declined at about 28% appetite to eat over a following period of 5 hours, in contrast to meals without consumption of avocado. Furthermore, over a following period of 3 hours, the consumption of avocado led to 26% increase in satisfaction and 40% reduction on desire to eat, in contrast to a meal without avocado [91,92]. A recent study observed that 240 g dose of freeze-dried avocado pulp—when consumed by participants with type 2 diabetes mellitus, cardiovascular diseases (CVD), and cerebrovascular diseases—led to inhibition of platelet aggregation [93]. In a randomized controlled trial the authors administered 136 g doses of avocado pulp to 45 overweight and obese adults with cardiovascular disease and concluded beneficial effects on cardiovascular and metabolic risk factors [94]. In other randomized controlled trial was observed that consuming one avocado per day among a sample of 48 healthy, non-smoking women and men with macular pigment density (MPD) led to increased macular pigment density MPD levels [88].
As a conclusion from the literature survey, scientific data about the effect of avocado on body weight are limited. More studies are needed for further investigation of its consumption on weight control possibly due to their high content in fiber; however, it is clear that avocado is a fruit which can contribute to improved metabolic parameters.
Table 6 presents several human intervention studies about the possible effects of olive oil and avocado on body weight control, obesity, and its metabolic consequences.

2.8. Ginger

Ginger is one of the most extensively used spices and medicinal plants. Ginger is Zingiber officinale Roscoe and belongs to Zingiberaceae family. It is rich in volatile oils ranging 1–3%, mainly terpenoids such as zingiberene, and pungent constituents such as gingerol, shogaol, and zingerone. The main bioactive constituents of fresh and dried ginger are gingerols and shogaols [95]. Ginger may exert anti-inflammatory, anti-hypertensive, and analgesic properties and it may be used in order to reduce delayed onset muscle soreness (DOMS) after high-intensity exercise. Furthermore, several studies support that ginger could be involved in weight control, but the results are controversial [96]. In a recent study, 5 days of treatment with 4 g of ginger demonstrated a significant reduction in muscle damage biomarkers following eccentric exercise [97,98,99].

Possible Effects of Ginger on Weight Control: Possible Mechanisms

The exact mechanisms of the possible anti-obesity effect of ginger are not well studied. However, some possible mechanisms through which Zingiber officinal could affect body weight and body composition has been investigated [95]. Ginger may modulate obesity via various potential ways, such as increasing thermogenesis and lipolysis, suppression of lipogenesis, inhibition of intestinal fat absorption, and controlling appetite [100]. In a animal study the authors observed possible effect of 500 mg/kg of ginger for 30 days in a sample of rats with type I diabetes mellitus [18]. A randomized controlled trial concluded that 2 g of ginger when consumed from 5 men and 5 women for 5 days affected muscle damage [97]. Other study showed that the consumption of 1g ginger from 10 overweight men for 6 weeks led to increase of body weight and food consumption [96]. In a recent study was observed that consumption of 2 g of ginger by 44 patients with non alcocholic fatty liver disease for 12 weeks decreased patients’ BMI [100].
The most studied mechanisms about the possible effect of ginger on body weight control are the following (Figure 1). (a) Increase of thermogenesis and energy expenditure: the catecholamine releasing action of ginger compounds may affect the beta adrenergic receptors and stimulate the sympathetic nerve system with the result of increased expression of uncoupling protein 1, which promotes thermogenesis [96]. (b) Increase of lipolysis: Ginger consumption may promote the activity of hormone sensitive lipase enzyme by activation of the sympathetic nerve system and thus increase the lipolysis in the white adipose tissue [101]. (c) Suppresses lipogenesis and lipid accumulation: It was reported that the bioactive compounds of ginger may exhibit antagonistic activity toward specific molecules, such as peroxisome proliferator-activated receptor sigma/beta and delta with the result of decrease of lipids accumulation in the skeletal muscle and in the adipose tissue [102]. Ginger components may also affect the expression of specific enzymes related to the lipogenesis, such as fatty acid synthase and acetyl CoA carboxylase [103]. (d) Suppresses adipogenesis: Treatment with ginger’s bioactive compounds reduced the adipogenesis in adipocytes (3T3-L1), possibly because it decreased the expression of PPARγ-associated genes. However, there are some controversial results relevant to the agonistic [103,104] or antagonistic effects of ginger on PPARγ [105,106]. (e) Inhibition of the intestinal absorption of dietary fat: It was reported in animal models that ginger may suppress pancreatic lipase enzyme; thus decreasing intestinal absorption of dietary fatty acids [95]. (f) Control of appetite: Ginger supplementation may lead to appetite attenuation [96,100]; nevertheless, the results about this mechanism are controversial [88]. Two contradictory hypotheses concerning ginger’s mechanism of action on appetite have been reported. Ginger has an inflecting effect on 5-hydroxytryptamine (5-HT; serotonin). The main elements of ginger could control the appetite, possibly through conjugation with 5-HT2c receptors in the central nervous system [97,107]. However, according to the other hypothesis, ginger may act as an appetizer through an adjusting effect on intestinal 5-HT receptors (such as 5-HT3) that raises gastrointestinal tract peristalsis and reduces the food transit time [104,108,109,110,111]; in addition, ginger consumption may reduce leptin levels [103,111,112,113].
Table 7 presents several human intervention studies about the possible effects of ginger on body weight control, obesity, and its metabolic consequences. The literature review showed that the studies are contradictory; several studies showed evidence and some mechanisms have been proposed.

3. Conclusions

Functional foods, when consumed as part of a balanced diet, have been proposed as a possible alternative method of weight management and obesity prevention and of improving of the metabolic consequences of obesity, including increased glucose and lipid levels. In recent years, many animal studies, as well as human clinical trials and epidemiological studies, have been performed in order to investigate the possible effect of specific functional foods and their bioactive compounds on weight control and several mechanisms of its effect have been proposed.
Several studies have shown that coffee caffeine and green tea catechins may decrease body weight, BMI, and body fat mass and help with weight control. However, the results are controversial, especially for coffee; other studies showed that the consumption of coffee increased body mass. The possible anti-obesity mechanisms of coffee and tea still need further clarification and they might have perspective as a novel strategy in order to prevent or treat obesity. In some human studies, specific kinds of berries, as well as pomegranate, led to increased fat oxidation, decreased body weight, and waist circumference, while preventing obesity’s metabolic consequences. However, more studies are needed for further investigation of berries’ anthocyanin effects on weight management. Although nuts are rich in fatty compounds, their consumption was not correlated, in the most of studies, with increased body weight, while they were associated with maintenance of body weight, helping in weight control, and increase of satiety. Furthermore, the moderate consumption of olive oil and avocado, which are also rich in fatty compounds, seems not to increase or in contrast decrease BMI, helping in weight control. Finally, studies about the consumption of ginger have shown controversial results; some studies led to increased body weight and others to reduced BMI.
To the best of our knowledge, the present review article is an attempt to critically summarize the basic findings of recent studies about the possible effect of specific functional foods and bioactive compounds on weight management and obesity’s consequences. In our opinion, this article may contribute to the better understanding of the existing research in this field and drive for further scientific investigation. However, it is not a systematic review, but a literature review article. Beyond the presented functional foods, some scientific data indicate possible effects on body control and for other foods, such as hot pepper, grapefruits, foods rich in fiber, foods rich in calcium, etc. However, in the present study, we chose to review the scientific evidence for specific functional foods that have been mentioned in a larger number of articles.
Summarizing the basic results of this review article, we could underline that, according to animal and clinical studies, specific bioactive compounds and functional foods may play a beneficial role on weight management and on attenuation of the metabolic consequences of increased body weight. However, the evidence is controversial and possible different effects have been observed from several studies. As the present literature review article indicated, most of the scientific data suggest that specific functional foods, as part of a balanced diet, could be useful in weight management and decreasing obesity’s metabolic consequences. However, their role remains unclear in most cases. Thus, more clinical and epidemiological studies are needed in order to exact safer results and conclusions and to further investigate the mechanisms of their possible effect.

Author Contributions

Conceptualization, A.E.K.; Data curation, M.K.; Investigation, M.K.; Methodology, A.E.K.; Project administration, A.E.K.; Resources, M.K.; Supervision, A.E.K.; Validation, A.E.K.; Writing—original draft, M.K. and A.E.K.; Writing—review & editing, A.E.K.

Funding

This research received no external funding.

Acknowledgments

The article is part of PhD thesis of Melina Konstantinidi in the University of the Aegean.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Materko, W.; Roberto, P.; Carvalho, A.; Nadal, J.; Santos, E.L. Accuracy of the WHO’s body mass index cut-off points to measure gender- and age-specific obesity in middle-aged adults living in the city of Rio de Janeiro, Brazil. JPHR 2017, 6, 904. [Google Scholar] [CrossRef]
  2. Farajian, P.; Risvas, G.; Karasouli, K.; Pounis, G.D.; Kastorini, C.M.; Panagiotakos, D.B.; Zampelas, A. Very high childhood obesity prevalence and low adherence rates to the Mediterranean diet in Greek children: The GRECO study. Atherosclerosis 2011, 217, 525–530. [Google Scholar] [CrossRef] [PubMed]
  3. Rolls, B.J. What is the role of portion control in weight management. Int. J. Obes. 2014, 38, 1–8. [Google Scholar] [CrossRef] [PubMed]
  4. Brown, L.; Poudyal, H.; Panchal, S.K. Functional foods as potential therapeutic options for metabolic syndrome. Obes. Rev. 2015, 16, 914–941. [Google Scholar] [CrossRef] [PubMed]
  5. Brown, L.; Caligiuri, S.; Brown, D.; Pierce, G. Clinical trials using functional foods provide unique challenges. J. Funct. Foods 2018, 45, 233–238. [Google Scholar] [CrossRef]
  6. Martirosyan, D.; Singh, J. A new definition of functional food by FFC: What makes a new definition unique? Functional Foods in Health and Disease. FFHD 2015, 5, 209–223. [Google Scholar] [CrossRef]
  7. Ntrigiou, V.; Ntrigios, I.; Rigopoulos, N.; Dimou, C.; Koutelidakis, A. Functional food consumption correlates with anthropometric characteristics and body composition in healthy adults. Curr. Top. Nutraceut. Res. 2019, 18, 279–288. [Google Scholar]
  8. Elmaliklis, I.N.; Liveri, A.; Ntelis, B.; Paraskeva, K.; Goulis, I.; Koutelidakis, A. Increased Functional Foods’ Consumption and Mediterranean Diet Adherence May Have a Protective Effect in the Appearance of Gastrointestinal Diseases: A Case–Control Study. Medicines 2019, 6, 50. [Google Scholar] [CrossRef]
  9. Koutelidakis, A.; Dimou, C. The effects of functional food and bioactive compounds on biomarkers of cardiovascular diseases. In Functional Foods Text Book, 1st ed.; Martirosyan, D., Ed.; Functional Food Center: Dallas, TX, USA, 2016; pp. 89–117. Available online: https://www.amazon.com/Functional-Foods-Chronic-Diseases-Textbook/dp/1536919438 (accessed on 15 February 2019).
  10. Karasawa, M.G.; Chakravarthi, M. Fruits as Prospective Reserves of bioactive Compounds: A Review. Nat. Prod. Bioprospect. 2018, 8, 335–346. [Google Scholar] [CrossRef] [Green Version]
  11. Cianciosia, D.; Valera-Lopez, A.; Forbes-Hermandez, T.Y.; Gasparrini, M.; Afrin, S.; Reboredo-Rodrigueza, P.; Zhang, J.; Quiles, J.L.; Nabav, S.F.; Battino, M.; et al. Targeting Molecular Pathways in Cancer Stem Cells by Natural Bioactive Compounds. Pharmacol. Res. 2018, 135, 150–165. [Google Scholar] [CrossRef]
  12. Masheb, R.M.; Ruser, C.; Min, K.M.; Bullock, A.J.; Dorflinger, L. Does food addiction contribute to excess weight among clinic patients seeking weight reduction? Examination of the Modified Yale Food Addiction Survey. Compr. Psychiatry 2018, 84, 1–6. [Google Scholar] [CrossRef] [PubMed]
  13. Fortuna, J.L. The Obesity Epidemic and Food Addiction: Clinical Similarities to Drug Dependence. J. Psychoact. Drugs 2012, 44, 56–63. [Google Scholar] [CrossRef] [PubMed]
  14. Panchal, S.K.; Poudyal, H.; Waanders, J.; Brown, L. Coffee Extract Attenuates Changes in Cardiovascular and Hepatic Structure and Function without Decreasing Obesity in High-Carbohydrate, High-Fat Diet-Fed Male Rats. J. Nutr. 2012, 142, 690–697. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Pan, M.H.; Tung, Y.C.; Yang, G.; Li, S.; Ho, C.T. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee. Food Funct. 2016, 7, 4481–4491. [Google Scholar] [CrossRef] [PubMed]
  16. Nekooeian, A.A.; Khalili, A.; Khosravi, M.B. Oleuropein offers cardioprotection in rats with simultaneous type 2 diabetes and renal hypertension. Indian J. Pharmacol. 2014, 46. [Google Scholar] [CrossRef] [PubMed]
  17. Gupta, V.; Mah, X.J.; Garcia, M.C.; Antonypillai, C.; van der Poorten, D. Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease. World J. Gastroenterol. 2015, 21, 10621–10635. [Google Scholar] [CrossRef]
  18. Abdulrazaq, N.B.; Cho, M.; Win, N.; Zaman, R.; Rahman, M.T. Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats. Br. J. Nutr. 2011, 108, 1194–1201. [Google Scholar] [CrossRef]
  19. Nohara, C.; Yokoyama, D.; Tanaka, W.; Sogon, T.; Sakono, M.; Sakakibara, H. Daily Consumption of Bilberry (Vacciniummyrtillus L.) Extracts Increases the Absorption Rate of Anthocyanins in Rats. J. Agric. Food Chem. 2018, 66, 7958–7964. [Google Scholar] [CrossRef]
  20. Martin, D.A.; Smyth, J.A.; Liu, Z.; Bolling, B.W. Aronia berry (Aroniamitschurinii‘Viking’) inhibits colitis in mice and inhibits T cell tumour necrosis factor-α secretion. J. Functional. Foods 2018, 44, 48–57. [Google Scholar] [CrossRef]
  21. Onwuli, D.O.; Brown, H.; Ozoani, H.A. Antihyperglycaemic Effect of TetracarpidiumConophorum Nuts in Alloxan Induced Diabetic Female Albino Rats. ISRN Endocrinol. 2014, 1–4. [Google Scholar] [CrossRef]
  22. Jose, T.; Pattanaik, A.K.; Jadhav, S.E.; Dutta, N.; Sharma, S. Nutrient digestibility, hindgut metabolites and antioxidant status of dogs supplemented with pomegranate peel extract. J. Nutr. Sci. 2017, 36, 1–5. [Google Scholar] [CrossRef] [PubMed]
  23. Bae, J.H.; Park, J.H.; Im, S.; Song, D.K. Coffee and health. Integr. Med. Res. 2014, 3, 189–191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Sarriá, B.; Martínez-López, S.; Sierra-Cinos, J.L.; García-Diz, L.; Mateos, R.; Bravo-Clemente, L. Regularly consuming a green/roasted coffee blend reduces the risk of metabolic syndrome. Eur. J. Nutr. 2016, 57, 269–278. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Nuhu, A.A. Bioactive Micronutrients in Coffee: Recent Analytical Approaches for Characterization and Quantification. ISRN 2014. [Google Scholar] [CrossRef] [PubMed]
  26. Tamara, B.; Boehm, N.; Janzowski, C.; Lang, R.; Hofmann, T.; Stockis, J.P.; Albert, F.W.; Stiebitz, H.; Bytof, G.; Lantz, I.; et al. Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: Results from an intervention study. Mol. Nutr. Food Res. 2011, 55, 793–797. [Google Scholar] [CrossRef]
  27. Burwell, H.; Vilsack, H. Dietary Guidelines Advisory Committee USDA. DGAC 2015, Chapter 1–7. Available online: https://health.gov/dietaryguidelines/2015-scientific-report/pdfs/scientific-report-of-the-2015-dietary-guidelines-advisory-committee.pdf (accessed on 15 February 2019).
  28. Beaudoin, M.S.; Robinson, L.E.; Graham, T.E. An Oral Lipid Challenge and Acute Intake of Caffeinated Coffee Additively Decrease Glucose Tolerance in Healthy Men. J. Nutr. 2011, 141, 574–581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  29. Zuchinali, P.; Souza, G.C.; Pimentel, M.; Chemello, D.; Zimerman, A.; Giaretta, V.; Salamoni, J.; Fracasso, B.; Zimerman, L.I.; Rohde, L.E. Short-term Effects of High-Dose Caffeine on Cardiac Arrhythmias in Patients With Heart Failure: A Randomized Clinical Trial. JAMA Intern. Med. 2016, 176, 1752–1759. [Google Scholar] [CrossRef]
  30. Martinez-Saez, N.; Ullate, M.; Martin-Cabrejas, M.A.; Martorell, P.; Genovis, S.; Ramon, D.; Castillo, M.D. A novel antioxidant beverage for body weight control based on coffee Silverskin. Food Chem. 2014, 150, 227–234. [Google Scholar] [CrossRef]
  31. Onakpoya, I.; Terry, R.; Ernst, E. The Use of Green Coffee Extract as a Weight Loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials. Gastroenterol. Res. Pract. 2011, 1–6. [Google Scholar] [CrossRef]
  32. Laurence, G.; Wallman, K.G. Effects of caffeine on time trial performance in sedentary men. J. Sports Sci. 2012, 30, 1235–1240. [Google Scholar] [CrossRef]
  33. Moisey, L.L.; Robinson, L.E.; Graham, T.E. Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br. J. Nutr. 2010, 103, 833–841. [Google Scholar] [CrossRef] [PubMed]
  34. Schubert, M.M.; Irwin, C.; Seay, R.F.; Clarke, H.E.; Allegro, D.; Desbrow, B. Caffeine, coffee, and appetite control: A review. Int. J. Food Sci. Nutr. 2017, 68, 901–912. [Google Scholar] [CrossRef] [PubMed]
  35. Renouf, M.; Guy, P.; Marmet, C.; Longet, K.; Fraering, A.L.; Moulin, J.; Barron, D.; Dionisi, F.; Cavin, C.; Steiling, H.; et al. Plasma appearance and correlation between coffee and green tea metabolites in human subjects. Br. J. Nutr. 2010, 104, 1635–1640. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Hu, J.; Webster, D.; Cao, J.; Shao, A. The safety of green tea and green tea extract consumption in adults Results of a systematic review. Regul. Toxicol. Pharmacol. 2018, 95, 412–433. [Google Scholar] [CrossRef] [PubMed]
  37. Yan, J.Q.; Yan, Z.; BaoLu, Z. Green tea catechins prevent obesity through modulation of peroxisome proliferator-activated receptors. Sci. China Life 2013, 56, 804–810. [Google Scholar] [CrossRef] [Green Version]
  38. Kongpichitchoke, T.; Chiu, M.T.; Huang, T.C.; Hsu, J.L. Gallic Acid Content in Taiwanese Teas at Different Degrees of Fermentation and Its Antioxidant Activity by Inhibiting PKC_ Activation: In Vitro and in Silico Studies. Molecules 2016, 21, 1346. [Google Scholar] [CrossRef] [PubMed]
  39. Suzuki, T.; Pervin, M.; Goto, S.; Isemura, M.; Nakamura, Y. Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity. Molecules 2016, 21, 1305. [Google Scholar] [CrossRef] [PubMed]
  40. Macedo Mendes, R. Quantification of catechins and caffeine from green tea (Camellia sinensis) infusions, extract, and ready-to-drink beverages-Quantificação de catequinas e cafeína do cháverde (Camellia sinensis) infusão, extrato e bebidaprontο. Ciênc. Tecnol. Aliment. 2010, 32, 163–166. [Google Scholar] [CrossRef]
  41. Koutelidakis, A.; Kapsokefalou, M. Holistic approaches of tea bioactivity: Interactions of tea and meal components studied in vitro and in vivo. In Tea in Health and Disease Prevention; Preedy, V., Ed.; Elsevier: Amsterdam, The Netherlands, 2012; pp. 36–42. [Google Scholar]
  42. Yang, C.S.; Zhang, J.; Zhang, L.; Huang, J.; Wang, Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol. Nutr. Food Res. 2016, 60, 160–174. [Google Scholar] [CrossRef]
  43. Gosselin, C.; Haman, F. Effects of green tea extracts on non shivering thermogenesis during mild cold exposure in young men. Br. J. Nutr. 2013, 110, 282–288. [Google Scholar] [CrossRef]
  44. Yoneshiro, T.; Aita, S.; Kawai, Y.; Iwanaga, T.; Saito, M. Nonpungent capsaicin analogs (capsinoids) increase energy expenditure through the activation of brown adipose tissue in humans. Am. J. Clin. Nutr. 2012, 95, 845–850. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Morrison, S.F.; Nakamura, K. Central neural pathways for thermoregulation. Front. Biosci. 2011, 16, 74–104. [Google Scholar] [CrossRef] [Green Version]
  46. Janssens, P.; Hursel, R.; Westerterp-Plantenga, M.S. Nutraceuticals for body-weight management: The role of green tea catechins. Physiol. Behav. 2016, 162, 83–87. [Google Scholar] [CrossRef] [PubMed]
  47. Toolsee, N.A.; Aruoma, O.I.; Gunness, T.K.; Kowlessur, S.; Dambala, V.; Murad, F.; Googoolye, K.; Daus, D.; Indelicato, J.; Rondeau, P.; et al. Effectiveness of Green Tea in a Randomized Human Cohort: Relevance to Diabetes and Its Complications. BioMed Res. Int. 2013, 1–12. [Google Scholar] [CrossRef] [PubMed]
  48. Chen, I.J.; Chia-Yu, L.; Jung-Peng, C.; Chung-Hua, H. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2016, 35, 592–599. [Google Scholar] [CrossRef] [PubMed]
  49. Basu, A.; Sanchez, K.; Leyva, M.J.; Wu, M.; Betts, N.M.; Aston, C.E.; Lyons, T.J. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 2010, 29, 31–40. [Google Scholar] [CrossRef] [PubMed]
  50. Egert, S.; Tereszczuk, J.; Wein, S.; Muller, M.J.; Frank, J.; Rimbach, G.; Wolffram, S. Simultaneous ingestion of dietary proteins reduces the bioavailability of galloylatedcatechins from green tea in humans. Eur. J. Nutr. 2012, 52, 281–288. [Google Scholar] [CrossRef] [PubMed]
  51. Mahler, A.; Steiniger, J.; Bock, M.; Klug, L.; Parreidt, N.; Lorenz, M.; Zimmermann, B.F.; Krannich, A.; Paul, F.; Boschmann, M. Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: A randomized clinical trial. Am. J. Clin. Nutr. 2015, 101, 487–495. [Google Scholar] [CrossRef] [PubMed]
  52. Koutelidakis, A.; Rallidis, L.; Koniari, K.; Panagiotakos, D.; Komaitis, M.; Zampelas, A.; Anastasiou-Nana, M.; Kapsokefalou, M. Effect of green tea on postprandial antioxidant capacity, serum lipids, C-reactive protein and glucose levels in patients with coronary artery disease. Eur. J. Nutr. 2013, 1–8. [Google Scholar] [CrossRef]
  53. Basu, A.; Du, M.; Sanchez, K.; Leyva, M.J.; Betts, N.M.; Blevins, S.; Wu, M.; Aston, C.E.; Lyons, T.J. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 2011, 27, 206–213. [Google Scholar] [CrossRef] [Green Version]
  54. Yamashita, Y.; Wang, L.; Wang, L.; Tanaka, Y.; Zhang, T.; Ashida, H. Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase. Food Funct. 2014, 5, 2420–2429. [Google Scholar] [CrossRef] [PubMed]
  55. Perez-Jimenez, J.; Neveu, V.; Vos, F.; Scalbert, A. Identification of the 100 richest dietary sources of polyphenols: An application of the Phenol-Explorer database. Eur. J. Clin. Nutr. 2010, 64, 112–120. [Google Scholar] [CrossRef] [PubMed]
  56. Kowalska, K.; Olejnik, A. Current evidence on the health-beneficial effects of berry fruits in the prevention and treatment of metabolic syndrome. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 446–452. [Google Scholar] [CrossRef] [PubMed]
  57. Nilsson, A.; Salo, I.; Plaza, M.; Bjorck, I. Effects of a mixed berry beverage on cognitive functions and cardiometabolic risk markers; A randomized cross-over study in healthy older adults. PLoS ONE 2017, 12, e0188173. [Google Scholar] [CrossRef] [PubMed]
  58. Choi, H.S.; Kim, S.; Kim, M.J.; Kim, M.S.; Kim, J.; Park, C.W.; Seo, D.; Shin, S.S.; Sang, W.O. Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial. J. Ginseng Res. 2017, 42, 90–97. [Google Scholar] [CrossRef] [PubMed]
  59. Lehtonen, H.M.; Suomela, J.P.; Tahvonen, R.; Vaarno, J.; Venojarvi, M.; Viikari, J.; Kallio, J. Berry meals and risk factors associated with metabolic syndrome. Eur. J. Clin. Nutr. 2010, 64, 614–621. [Google Scholar] [CrossRef]
  60. Batista, Â.G.; Soares, E.S.; Mendonça, M.; Silva, J.K.; Dionísio, A.P.; Sartori, C.R.; Cruz-Höfling, M.A.; MarósticaJúnior, M.R. Jaboticaba berry peel intake prevents insulin resistance-induced tau phosphorylation in mice. Mol. Nutr. Food Res. 2017, 61. [Google Scholar] [CrossRef]
  61. Solverson, P.; Rumpler, W.; Leger, J.; Redan, B.; Ferruzzi, M.; Baer, D.; Castonguay, T.; Novotny, J. Blackberry Feeding Increases Fat Oxidation and Improves Insulin Sensitivity in Overweight and Obese Males. Nutrients 2018, 10, 1048. [Google Scholar] [CrossRef]
  62. Fischer, U.A.; Carle, R.; Kammerer, D.R. Identification and quantification of phenolic compounds from pomegranate (Punicagranatum L.) peel, mesocarp, aril and differently produced juices by HPLC-DAD-ESI/MSn. Food Chem. 2011, 127, 807–821. [Google Scholar] [CrossRef]
  63. Zhao, X.; Yuan, Z.; Fang, Y.; Yin, Y.; Feng, L. Flavonols and Flavones Changes in Pomegranate (Punicagranatum L.) Fruit Peel during Fruit Development. J. Agric. Sci. Technol. 2014, 16, 1649–1659. [Google Scholar]
  64. Singh, B.; Singh, J.P.; Kaur, A.; Singh, N. Phenolic compounds as beneficial phytochemicals in pomegranate (Punicagranatum L.) peel: A review. Food Chem. 2018, 261, 75–86. [Google Scholar] [CrossRef] [PubMed]
  65. Arun, K.B.; Jayamurthy, P.; Anusha, C.V.; Mahesh, S.K.; Nisha, P. Studies on activity guided fractionation of pomegranate peel extracts and its effect on antidiabetic and cardiovascular protection properties. J. Food Process. Preserv. 2016, 1745–4549. [Google Scholar] [CrossRef]
  66. Ambigaipalan, P.; de Camargo, A.C.; Shahidi, F. Identification of phenolic antioxidants and bioactives of pomegranate seeds following juice extraction using HPLC-DAD-ESIMS. Food Chem. 2016, 221, 1883–1894. [Google Scholar] [CrossRef] [PubMed]
  67. Medjakovic, S.; Jungbauer, A. Pomegranate: A fruit that ameliorates metabolic syndrome. Food Funct. 2013, 4, 19–39. [Google Scholar] [CrossRef] [PubMed]
  68. Lehtonen, H.M.; Suomela, J.P.; Tahvonen, R.; Yang, B.; Venojarvi, M.; Viikari, J.; Kallio, H. Different berries and berry fractions have various but slightly positive effects on the associated variables of metabolic diseases on overweight and obese women. Eur. J. Clin. Nutr. 2011, 65, 394–401. [Google Scholar] [CrossRef] [Green Version]
  69. Ros, E.; Tapsell, L.C.; Sabaté, J. Nuts and Berries for Heart Health. Curr. Atheroscler. Rep. 2010, 12, 397–406. [Google Scholar] [CrossRef] [PubMed]
  70. Kalogeropoulos, N.; Chiou, A.; Ioannou, M.S.; Karathanos, V.T. Nutritional evaluation and health promoting activities of nuts and seeds cultivated in Greece. Int. J. Food Sci. Nutr. 2013, 64, 757–767. [Google Scholar] [CrossRef]
  71. Hu, F.B.; Manson, J.E. Omega-3 fatty acids and secondary prevention of cardiovascular disease—Is it just a fish tale? Comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch. Intern. Med. 2012, 172, 694–696. [Google Scholar]
  72. Sánchez-González, C.; Izquierdo-Pulido, M. Health Benefits of Walnut Polyphenols: An Exploration beyond Their Lipid Profile. Crit. Rev. Food Sci. Nutr. 2015, 1–42. [Google Scholar] [CrossRef]
  73. Coates, A.M.; Howe, P.R.C. Edible nuts and metabolic health. Curr. Opin. Lipidol. 2007, 18, 25–30. [Google Scholar] [CrossRef]
  74. Kranz, S.; Hill, A.M.; Fleming, J.A.; Hartman, T.J.; West, S.J.; Kris-Etherton, P.M. Nutrient displacement associated with walnut supplementation in men. J. Hum. Nutr. Diet 2013, 27, 247–254. [Google Scholar] [CrossRef] [PubMed]
  75. Casas-Agustench, P.; Lo´pez-Uriarte, P.; Bullo, M.; Ros, E.; Cabre´-Vila, J.J.; Salas-Salvado, J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 126–135. [Google Scholar] [CrossRef] [PubMed]
  76. Mohan, V.; Gayathri, R.; Jaacks, L.M.; Lakshmipriya, N.; Mohan, A.R.; Spiegelman, D.; Jeevan, R.G.; Balasubramaniam, K.; Shobana, S.; Jayanthan, M.; et al. Cashew Nut Consumption Increases HDL Cholesterol and Reduces Systolic Blood Pressure in Asian Indians with Type 2 Diabetes: A 12-Week Randomized Controlled Trial. J. Nutr. 2018, 148, 63–69. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Katz, D.L.; Davidhi, A.; Yingying, M.; Kavak, Y.; Bifulco, L.; YanchouNjike, V. Effects of Walnuts on Endothelial Function in Overweight Adults with Visceral Obesity: A Randomized, Controlled, Crossover Trial Yale University Prevention Research Center, Griffin Hospital, Derby, A Randomized, Controlled, Crossover Trial. J. Am. Coll. Nutr. 2013, 31, 415–423. [Google Scholar] [CrossRef]
  78. Tan, S.Y.; Mattes, R.D. Appetitive, dietary and health effects of almonds consumed with meals or as snacks: A randomized, controlled trial. Eur. J. Clin. Nutr. 2013, 67, 1205–1214. [Google Scholar] [CrossRef] [PubMed]
  79. Martin-Pelaez, S.; Covas, M.I.; Fito, M.; Kusar, A.; Pravs, I. Health effects of olive oil polyphenols: Recent advances and possibilities for the use of health claims. Mol. Nutr. Food Res. 2013, 57, 760–771. [Google Scholar] [CrossRef] [PubMed]
  80. Brinkman, M.T.; Buntinx, F.; Kellen, E.; Van Dongen, M.; Dagnelie, P.C.; Muls, E.; Zeegers, M.P. Consumption of animal products, olive oil and dietary fat and results from the Belgian case–control study on bladder cancer risk. Eur. J. Cancer 2011, 47, 436–442. [Google Scholar] [CrossRef] [PubMed]
  81. Psaltopoulou, T.; Kosti, R.I.; Haidopoulos, D.; Dimopoulos, M.; Panagiotakos, D.B. Olive oil intake is inversely related to cancer prevalence: A systematic review and a metaanalysis of 13.800 patients and 23.340 controls in 19 observational studies. Lipids Health Dis. 2011, 10, 127. [Google Scholar] [CrossRef] [PubMed]
  82. Muzzalupo, I.; Stefanizzi, F.; Perri, E.; Chiappetta, A. Transcript levels of CHL P gene, antioxidants and chlorophylls contents in olive oleaeuropaea pericarps: A comparative study on eleven olive cultivars harvested in two ripening stages. Plant Foods Hum. Nutr. 2011, 66, 1–10. [Google Scholar] [CrossRef] [PubMed]
  83. Rezaei, S.; Akhlaghi, M.; Sasani, M.R.; Boldaji, R. Olive oil improved fatty liver severity independent of cardiometabolic correction in patients with 2 non-alcoholic fatty liver disease, a randomized clinical trial. Nutrition 2018, 57, 154–161. [Google Scholar] [CrossRef] [PubMed]
  84. Camargo, A.; Ruano, J.; Fernandez, J.M.; Parnell, L.D.; Jimenez, A.; Santos-Gonzalez, M.; Marin, C.; Perez-Martinez, P.; Uceda, M.; Lopez-Miranda, J.; et al. Gene expression changes in mononuclear cells in patients with metabolic syndrome after acute intake of phenol-rich virgin olive oil. BMC Genom. 2010, 11, 253. [Google Scholar] [CrossRef] [PubMed]
  85. Moreno-Luna, R.; Muñoz-Hernandez, R.; Miranda, M.L.; Costa, A.L.; Jimenez-Jimenez, L.; Vallejo-Vaz, A.J.; Muriana, F.; Villar, J.; Stiefel, P. Olive Oil Polyphenols Decrease Blood Pressure and Improve Endothelial Function in Young Women with Mild Hypertension. Am. J. Hypertens. 2012, 25, 1299–1304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  86. Nigam, P.; Bhatt, S.; Misra, A.; Chadha, D.S.; Vaidya, M.; Dasgupta, J.; Pasha, Q. Effect of a 6-Month Intervention with Cooking Oils Containing a High Concentration of Monounsaturated Fatty Acids (Olive and Canola Oils) Compared with Control Oil in Male Asian Indians with Nonalcoholic Fatty Liver Disease. Diabetes Technol. Ther. 2014, 16. [Google Scholar] [CrossRef] [PubMed]
  87. Kopec, R.E.; Cooperstone, J.L.; Schweiggert, R.M.; Young, G.; Harrison, E.; Francis, D.; Clinton, S.; Schwartz, S. Avocado Consumption Enhances Human Postprandial Provitamin A Absorption and Conversion from a Novel High–b-Carotene Tomato Sauce and from Carrots. The Journal of Nutrition. J. Nutr. 2015, 144, 1158–1166. [Google Scholar] [CrossRef] [PubMed]
  88. Scott, T.M.; Rasmussen, H.M.; Chen, O.; Johnson, E.J. Avocado Consumption Increases Macular PigmentDensity in Older Adults: A Randomized Controlled Trial. Nutrients 2017, 9, 919. [Google Scholar] [CrossRef] [PubMed]
  89. USDA (US. Department of Agriculture). Avocado, Almond, Pistachio and Walnut Composition. Nutrient Data Laboratory; USDA National Nutrient Database for Standard Reference, Release 24; Department of Agriculture: Washington, DC, USA, 2011.
  90. Pahua-Ramos, M.E.; Garduño-Siciliano, L.; Dorantes-Alvarez, L.; Chamorro-Cevallos, G.; Herrera-Martínez, J.; Osorio-Esquivel, O.; Ortiz-Moreno, A. Reduced-calorie Avocado Paste Attenuates Metabolic Factors Associated with a Hypercholesterolemic-high Fructose Diet in Rats. Plant Foods Hum. Nutr. 2014, 69, 18–24. [Google Scholar] [CrossRef] [PubMed]
  91. Wien, M.; Haddad, E.; Oda, K.; Sabate, J. A randomized 3 × 3 crossover study to evaluate the effect of Hass avocado intake on post-ingestive satiety, glucose and insulin levels, and subsequent energy intake in overweight adults. Nutr. J. 2013, 12, 155. [Google Scholar] [CrossRef]
  92. Dreher, M.L.; Davenport, A.J. Hass Avocado Composition and Potential Health Effects. Crit. Rev. Food Sci. Nutr. 2013, 53, 738–750. [Google Scholar] [CrossRef] [Green Version]
  93. Rodriguez-Sanchez, D.G.; Flores-García, M.; Silva-Platas, C.; Rizzo, S.; Torre-Amione, G.; De la Peña-Diaz, A.; Hernández-Brenes, C.; García-Rivas, G. Isolation and chemical identification of lipid derivatives from avocado (Perseaamericana) pulp with antiplatelet and antithrombotic activities. RSC Adv. 2015, 1–11. [Google Scholar] [CrossRef]
  94. Wang, L.; Bordi, P.L.; Fleming, J.A.; Hill, A.M.; Kris-Etherton, P.M. Effect of a Moderate Fat Diet with and Without Avocados on Lipoprotein Particle Number, Size and Subclasses in Overweight and Obese Adults: A Randomized Controlled Trial. J. Am. Heart Assoc. 2015, 4, 1355. [Google Scholar] [CrossRef]
  95. Mahmoud, R.H.; Elnour, W.A. Comparative evaluation of the efficacy of ginger and orlistat on obesity management, pancreatic lipase and liver peroxisomal catalase enzyme in male albino rats. European Review for Medical and Pharmacological Sciences. Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 75–83. [Google Scholar] [PubMed]
  96. Mansour, M.S.; Yu-Ming, N.; Roberts, A.M.; Kelleman, M.; RoyChoudhury, A.; St-Onge, M.P. Ginger consumption enhances the thermic effect of food and promotes feelings of satiety without affecting metabolic and hormonal parameters in overweight men: A pilot study. Metabolism 2012, 61, 1347–1352. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  97. Matsumura, M.D.; Gerald, S.; Zavorsky, G.S.; Smoliga, J.M. The Effects of Pre-Exercise Ginger Supplementation on Muscle Damage and Delayed Onset Muscle Soreness. Phytother. Res. 2015, 29, 887–893. [Google Scholar] [CrossRef] [PubMed]
  98. Black, C.D.; O’Connor, P.J. Acute effects of dietary ginger on muscle pain induced by eccentric exercise. Phytother. Res. 2010, 24, 1620–1626. [Google Scholar] [CrossRef] [PubMed]
  99. Black, C.D.; Herring, M.P.; Hurley, D.J.; O’Connor, P.J. Ginger (Zingiber officinale) reduces muscle pain caused by eccentric exercise. J. Pain 2010, 11, 894–903. [Google Scholar] [CrossRef] [PubMed]
  100. Attari, V.E.; Mahdavi, A.M.; Javadivala, Z.; Mahluji, S.; Vahed, S.Z.; Ostadrahimi, A. A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action. Phytother. Res. 2017, 32, 1–9. [Google Scholar] [CrossRef]
  101. Ahn, E.K.; Oh, J.S. Inhibitory effect of Galanolactone isolated from Zingiber officinale Roscoe extract on adipogenesis in 3T3-L1 cells. J. Korean Soc. Appl. Biol. Chem. 2012, 55, 63–68. [Google Scholar] [CrossRef]
  102. Misawa, K.; Hashizume, K.; Yamamoto, M.; Minegishi, Y.; Hase, T.; Shimotoyodome, A. Ginger extract prevents high-fat dietinduced obesity in mice via activation of the peroxisome proliferator activated receptor δ pathway. J. Nutr. Biochem. 2015, 26, 1058–1067. [Google Scholar] [CrossRef]
  103. Okamoto, M.; Irii, H.; Tahara, Y.; Ishii, H.; Hirao, A.; Udagawa, H.; Shimizu, I. Synthesis of a new [6]-gingerol analogue and its protective effect with respect to the development of metabolic syndrome in mice fed a high-fat diet. J. Med. Chem. 2011, 54, 6295–6304. [Google Scholar] [CrossRef]
  104. Abd Allah, E.S.; Makboul, R.; Mohamed, A.O. Role of serotonin and nuclear factor-kappa B in the ameliorative effect of ginger on acetic acid-induced colitis. Pathophysiology 2016, 23, 35–42. [Google Scholar] [CrossRef]
  105. Tzeng, T.F.; Liu, I.M. 6-gingerol prevents adipogenesis and the accumulation of cytoplasmic lipid droplets in 3T3-L1 cells. Phytomedicine 2013, 20, 481–487. [Google Scholar] [CrossRef] [PubMed]
  106. De lasHeras, N.; Valero-Muñoz, M.; Martín-Fernández, B.; Ballesteros, S.; López-Farré, A.; Ruiz-Roso, B.; Lahera, V. Molecular factors involved in the hypolipidemic-and insulin-sensitizing effects of a ginger (Zingiber officinale Roscoe) extract in rats fed a high-fat diet. Appl. Physiol. Nutr. Metab. 2017, 42, 209–215. [Google Scholar] [CrossRef] [PubMed]
  107. Palatty, P.L.; Haniadka, R.; Valder, B.; Arora, R.; Baliga, M.S. Ginger in the prevention of nausea and vomiting: A review. Crit. Rev. Food Sci. Nutr. 2013, 53, 659–669. [Google Scholar] [CrossRef] [PubMed]
  108. Hu, M.L.; Rayner, C.K.; Wu, K.L.; Chuah, S.K.; Tai, W.C.; Chou, Y.P.; Chiu, Y.C.; Chiu, K.W.; Hu, T.H. Effect of ginger on gastric motility and symptoms of functional dyspepsia. World J. Gastroenterol. 2011, 17, 105–110. [Google Scholar] [CrossRef] [PubMed]
  109. Jin, Z.; Lee, G.; Kim, S.; Park, C.S.; Park, Y.S.; Jin, Y.H. Ginger and its pungent constituents non-competitively inhibit serotonin currents on visceral afferent neurons. Korean J. Physiol. Pharmacol. 2014, 18, 149–153. [Google Scholar] [CrossRef] [PubMed]
  110. Lua, P.L.; Salihah, N.; Mazlan, N. Effects of inhaled ginger aromatherapy on chemotherapy-induced nausea and vomiting and healthrelated quality of life in women with breast cancer. Complementary Therapies in Medicine. Complement. Ther. Med. 2015, 23, 396–404. [Google Scholar] [CrossRef] [PubMed]
  111. Neveen, I. Protective effects of aqueous extracts of cinnamon and ginger herbs against obesity and diabetes in obese diabetic rat. World J. Dairy Food Sci. 2014, 9, 145–153. [Google Scholar] [CrossRef]
  112. Saravanan, G.; Ponmurugan, P.; Deepa, M.A.; Senthilkumar, B. Anti-obesity action of gingerol: Effect on lipid profile, insulin, leptin, amylase and lipase in male obese rats induced by a high-fat diet. J. Sci. Food Agric. 2014, 94, 2972–2977. [Google Scholar] [CrossRef]
  113. Wadikar, D.D.; Premavalli, K.S. Appetizer administration stimulates food consumption, weight gain and leptin levels in male Wistar rats. Appetite 2011, 57, 131–133. [Google Scholar] [CrossRef]
Figure 1. Possible mechanisms of ginger effect on body weight management.
Figure 1. Possible mechanisms of ginger effect on body weight management.
Medicines 06 00094 g001
Table 1. Animal studies about the possible effect of functional foods and bioactive compounds on body weight control, obesity, and its metabolic consequences
Table 1. Animal studies about the possible effect of functional foods and bioactive compounds on body weight control, obesity, and its metabolic consequences
Study Type
(Animals Used)
Number and Characteristics of AnimalsFunctional Food/Dose/DurationSummary of Key ResultsStudy Reference
Ratsn = 10 Male rats per 4 groups
with obesity
Green tea
100 mg capsules or powder (catechins)
30 days
Reduced body weight gainPan et al. 2016 [15]
Ratsn = 35 male rats with high cholesterol, body weight, blood glucose, serum lipidsAvocado
2 g avocado pulp
7 weeks
Increased cholesterol
Reduced body weight
Reduced blood glucose
Reduced BMI
Reduced serum lipids
Gupta et al. 2015 [17]
Ratsn = 40 male rats with metabolic syndrome, cardiovascular, and hepatic structureGreen coffee
68.3 mg/kg caffeine
8–9 weeks
Increased cardiovascular diseasesPauchal et al. 2012 [14]
Ratsn = 80 rats (2 groups) with chronic diseasesBerries
500 mg powder (anthocyanins)
7 weeks
Reduced chronic diseasesNohara et al. 2018 [19]
Mice acuten = 8–9 per group149 g powdered berry
Colitis and T cell tumournecrosis, factor-α secretion
Inhibited colitis in mice and T cell tumor necrosis factor-α secretionMartin et al. 2018 [20]
Ratsn = 40 male rats per 5 groups with diabetes mellitusNuts (walnuts)
85.2 g
2 weeks
Reduced blood glucose levelsOnwuli, et al. 2014 [21]
Ratsn = 8 male rats per 5 groups with Type 2 diabetes mellitus, increased blood pressureOlive (oleuropein)
20–60 mg/day powder RCT
4 weeks, acute
Increased blood pressure, glucoseNekooeian et al. 2014 [16]
Dogsn = 6 dogs with gut healthPomegranate
50 mg powder
Positive impact on gut healthJose et al. 2017 [22]
Rats5 groupsGinger
500 mg/kg, 30 days
Type 1 Diabetes mellitus
Increased liver weight
Decreased of plasma glucose levels
Abdulrazaq et al. 2011 [18]
Table 2. Human interventional clinical studies about the possible effect of coffee and caffeine on body weight control, obesity, and its metabolic consequences
Table 2. Human interventional clinical studies about the possible effect of coffee and caffeine on body weight control, obesity, and its metabolic consequences
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCT 1
4 weeks
n = 142 participants Green coffee 180 mgWeight lossOnakpoya et al., 2011 [31]
AcuteWomen1 cup, powder coffee
Caffeine, 0.83 and 1.37 g/100 g of silverskin
300 mg powder
Prevented fat accumulation
and excess weight
Martinez–Saez et al., 2014 [30]
RCT 1
3 weeks
n = 25 male, 95 female
with obesity
3–5 cups coffee/dayNo obesity, decreased body weight, BMI, and body fat content, helping in weight control, increased number of Bifidobacterium spp.Pan et al., 2016 [15]
RCT 1n = 306 patients
n = 782 adults
with increased insulin (diabetes)
6 cups/day coffeeReduced BMI
Low levels of insulin
Gupta et al., 2015 [17]
RCT 1n = 10 women and 12 mencaffeine 6 mgIncreased body massLaurence et al., 2012. [32]
RCT 1n = 10 Males, 18–50 years old, with Type II diabetes mellitus3–4 cups coffee per day acuteGlucose control improvedMoisey et al., 2009 [33]
RCBT 2
acute
n = 10 menCaffeine 80 mgAppetite controlSchubert et al., 2017 [34]
RCBT 2
acute
n = 10 Men with increased glucose, insulin5 mg caffeineDecreased glucose, insulinBeaudoin et al., 2011 [28]
RCT 1
acute
15% women with osteoporosis and 51% with low bone mass
4% men with osteoporosis and 35% with low bone mass
Caffeine 400 mg
Capsule or powder
No association with
increased risk of chronic diseases in healthy adults (premature death, cardiovascular diseases, and cancer)
US Dietary Guidelines Advisory Committee (DGAC), 2015 [27]
RCBT 2
acute
2 months
RCT 1
acute
n = 137 Patients with Arrhythmic episodesCaffeine 500 mg capsules or powder
Caffeine 35 mg capsules or powder
Decaffeinated coffee 100 mL or 4 cups/day capsules or powder
No arrhythmic
episodes
Zuchinali et al., 2016 [29]
RCT 1n = 9 healthy participants1–5 cups/day coffeeLimited plasma appearance of bioactives and metabolites of coffeeRenouf et al., 2010 [35]
1 RCT: randomized control trials, 2 RCBT: randomized control blinded trials.
Table 3. Human intervention clinical studies about the possible effects of green tea on body weight control, obesity and its metabolic consequences
Table 3. Human intervention clinical studies about the possible effects of green tea on body weight control, obesity and its metabolic consequences
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCBT 2
12 weeks
acute
n = 115 obese womenCatechins 491 mg capsulesWeight reductionChen et al., 2016 [48]
RCT 1
acute
n = 8821 adults with obesity and increased diastolic blood pressure
n = 35 obese people
3 cups/day capsules green tea
4 cups/day capsules green tea
Lower BMI
Higher diastolic blood pressure
BMI decreased
Basu, et al., 2010 [49]
RCT 1
acute
n = 24 participants women 23–32 years old4–5 cups capsules green teaBMI normal levelsEgert et al., 2012 [50]
RCT 1
acute
n = 159 human (adults) with hypatotoxicity risk, thyroid toxicity3 cups/day capsules green tea catechins 304 mgSubchronic-toxicity
carcinogenicity
thyroid toxicity
Hu et al., 2018 [36]
RCBT 2
14 days
14 weeks
acute
n = 40 male
n = 37 female with liver problems fasting plasma glucose,
hepatotoxicity
Catechins 704 mg
1 cup green tea
No adverse effects on liver no affect fasting plasma glucose
No hepatotoxic effect
Toolsee et al., 2013 [47]
RCT 1n = 8 young men Catechins
(EGCG) epigallocachin-3 gallate 90 mg capsules
caffeine 50 mg capsules
Stimulate thermogenesisGosselin et al., 2012 [43]
RCBT 2n = 18 patients (men) with muscle metabolismCatechins
epigallocachin-3 gallate (EGCG) 600 mg capsules
Improved muscle metabolismMähler, et al., 2015 [51]
RCT 1
acute
6 months
n = 43 patients with coronary artery disease4.5 g green teaDid not affect coronary artery disease
decreased postprandial triglycerides increase
Koutelidakis et al.,
2013 [52]
RCT 1
acute
n = 5 female, n = 4 male with obesity, metabolic syndrome4 cups/day capsules green teaNot significantly affected features of metabolic syndromeBasu et al., 2011 [53]
RCBT 2
7 days
90 obese people
30 overweight people
Retroperitoneal, epididymal,
mesenteric adipose tissues
Reduced retroperitoneal, epididymal,
mesenteric adipose tissues
Pan et al., 2016 [15]
RCBT 2
7 days
90 obese people
30 overweigh people
Catechins
68.99 mg capsules or powder
Reduced retroperitoneal, epididymal,
mesenteric adipose tissues
Yamashita et al., 2014 [54]
1 RCT: randomized control trials. 2 RCBT: randomized control blinded trials.
Table 4. Human intervention clinical studies about the possible effects of berries and pomegranate on body weight control, obesity, and its metabolic consequences
Table 4. Human intervention clinical studies about the possible effects of berries and pomegranate on body weight control, obesity, and its metabolic consequences
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCT 1
One week
n = 27 overweight or obese menBerries (Blackberry)
600 g
Increased fat oxidation
reduced insulin sensitivity
increased hepatic glucose
Solverson et al., 2018 [61]
RCT 1
35 days
acute
n = 101 overweight or
obese women with metabolic syndrome
100 g powdered berriesDecreased waist circumference and body weight—positive effects on metabolic diseasesLehtonen et al., 2011 [68]
RCT 1
20 weeks
acute
n = 61 women with decreased fasting plasma HDL-C and systolic and diastolic
blood pressure
163 g BerriesIncreased fasting plasma HDL-C
decreased systolic and diastolic blood pressures
Lehtonen et al., 2010 [59]
RCBT 2
12 weeks
acute
n = 63 participants
adults 20–79 years with diabetes mellitus, decreased glycemic control, increased fasting glucose
Berries
100–140 mg/dL in capsules
Increased glycemic control, decreased fasting glucoseChoi et al., 2017 [58]
RCT 1
5 weeks
n = 40 healthy older adults 50–70 years old with increased cardio-metabolic risk markersAnthocyanins 414.2 mg/L from berriesImprovements in
type II diabetes mellitus and cardiovascular disease biomarkers
Nilsson et al., 2017 [57]
RCT 1
acute
n = 21.13 million people
metabolic syndrome
Pomegranate leaf extract and
ascorbic acid 10–20 mg in capsules or powder
Treatment of obesity and type 2 diabetes mellitus
reduced body weight
Medjakovic et al., 2013 [67]
1 RCT: randomized control trials; 2 RCBT: randomized control blinded trials.
Table 5. Human intervention clinical studies about the possible effects of nuts on body weight control, obesity and its metabolic consequences
Table 5. Human intervention clinical studies about the possible effects of nuts on body weight control, obesity and its metabolic consequences
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCT 1
4 weeks
n = 46 (28 women, 18 men) overweight, obese adultsWalnuts 56 gImproved endothelial function in overweightKatz MD et al., 2012 [77]
RCT 1
acute
n = 21 Men 45–75 years with prostate cancer and overweightWalnuts 75 g/dayMaintained body weightKranz et al., 2013 [74]
RCT 1
12 weeks
n = 300 adults
51 years with type 2 diabetes mellitus
Cashew nuts 30 g/dayIncreased body weight, BMI, waist circumference, increased HDL cholesterol and reduced systolic blood pressureMohan et al., 2018 [76]
RCT 1n = 8800 (men, women)
obese, type 2 diabetes mellitus
67 g nutsReduced insulin levels, reduced LDL cholesterol, and increased HDL cholesterolRos et al., 2010 [69]
RCT 1
acute
n = 63 patients with prostate cancer or prostate hyperplasiaWalnuts 50 gImproved prostate biomarkersSánchez-González et al., 2015 [72]
RCT 1
12 week
sacute
n = 50 patients with insulin resistance30 g nutsDecreased insulin resistanceCasas-Agustench et al., 2011 [75]
RCT 1
4 weeks
acute
n = 137 participants with postprandial glycemiaAlmonds 43 gSuppressed hungerTan and Matteset al., 2013 [78]
1 RCT: randomized control trials.
Table 6. Human intervention clinical studies about the possible effects of olive oil and avocado on weight control, obesity, and its metabolic consequences.
Table 6. Human intervention clinical studies about the possible effects of olive oil and avocado on weight control, obesity, and its metabolic consequences.
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCT 1
6 months
n = 93 male patients with insulin resistanceOlive oil 20 g/dayReduction in BMI and increased insulin sensitivityGupta et al., 2015 [17]
Nigam P et al., 2014 [86]
RCBT 2
1 week
n = 26 healthy overweight adults with increased blood glucose and insulinAvocado 75 g or ½ avocadoInsulin resistant
varied BMI
Wien et al., 2013 [92]
RCBT 2
acute
n = 20 patients with metabolic syndromePhenolics (olive oil) 70–398 mgReduced cardiovascular diseaseCamargo et al., 2010 [84]
RCBT 2
2 months
n = 24 young women with mild hypertensionPolyphenols (olive oil) 30 mg/dayDecrease blood pressureMoreno-Luna et al., 2012 [85]
2 weeks3 Male adult mice per group
type 2 diabetes
cardiovascular diseases (CVD)
platelet aggregation
240 g freeze-dried avocado pulpInhibited platelet aggregationRodriguez-Sanchez et al., 2015 [93]
RCT 1n = 45 overweight and obese adults with Cardiovascular disease136 g avocado pulpBeneficial effects on cardiovascular and metabolic risk factorsWang et al., 2015 [94]
RCT 1
6 months
n = 48 healthy, non-smoking women and men with macular pigment density (MPD)AvocadoIncreased MPD levelsScott et al., 2017 [88]
1 RCT: randomized control trials; 2 RCBT: randomized control blinded trials.
Table 7. Human intervention clinical studies about the possible effects of ginger on body weight control, obesity, and its metabolic consequences
Table 7. Human intervention clinical studies about the possible effects of ginger on body weight control, obesity, and its metabolic consequences
Study Type/DurationParticipants/InterventionFunctional Food DoseSummary of Key ResultsStudy Reference
RCT 1
6 weeks
acute
n = 10 overweight men1 g gingerIncreased body weight and food consumptionMansour et al., 2012 [96]
RCT 1
12 weeks
n = 44 patients with non-alcoholic fatty liver disease2 g gingerDecreased BMIAttari et al., 2017 [100]
RCT 1
5 days
n = 5 men and n = 5 women with muscle damage2 g gingerIncreased muscle damageMatsumura et al., 2015 [97]
1 RCT: randomized control trials.

Share and Cite

MDPI and ACS Style

Konstantinidi, M.; Koutelidakis, A.E. Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences. Medicines 2019, 6, 94. https://doi.org/10.3390/medicines6030094

AMA Style

Konstantinidi M, Koutelidakis AE. Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences. Medicines. 2019; 6(3):94. https://doi.org/10.3390/medicines6030094

Chicago/Turabian Style

Konstantinidi, Melina, and Antonios E. Koutelidakis. 2019. "Functional Foods and Bioactive Compounds: A Review of Its Possible Role on Weight Management and Obesity’s Metabolic Consequences" Medicines 6, no. 3: 94. https://doi.org/10.3390/medicines6030094

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop